Join to View Full Profile
1611 NW 12th Ave# HoltzMiami, FL 33136
Phone+1 305-585-5068
Dr. Procop is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Duke University HospitalResidency, Pathology-Anatomic and Clinical, 1992 - 1996
Marshall University Joan C. Edwards School of MedicineClass of 1992
Certifications & Licensure
OH State Medical License 1998 - 2028
FL State Medical License 2006 - 2027
American Board of Pathology Anatomic Pathology & Clinical Pathology- American Board of Pathology Medical Microbiology
Awards, Honors, & Recognition
- Whos Who in Medicine and Healthcare Marquis Whos Who
Clinical Trials
- Performance Comparison of QuantiFERON Monitor in Solid Organ Transplant Recipients Start of enrollment: 2015 Jul 01
Publications & Presentations
PubMed
- A comparison of the suitability of items generated by 4 large language models for pathology continuing certification.Gary W Procop, Anthony Schlinsog, Colette Earnest, Ritu Nayar, Ty McCarthy
American Journal of Clinical Pathology. 2026-01-05 - The birth, life, and death of a cytopathology board examination question.Roseann I Wu, Ritu Nayar, Gary W Procop
Cancer Cytopathology. 2025-10-01 - Performance evaluation of plazomicin susceptibility testing of Enterobacterales on VITEK 2 and VITEK 2 Compact Systems.Edith Csiki-Fejer, Maria Traczewski, Gary W Procop, Thomas E Davis, Meredith Hackel
Journal of Clinical Microbiology. 2025-09-10
Journal Articles
- Association of Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers with Testing Positive for Coronavirus Disease 2019 (COVID-19)Andres E Carmona-Rubio, Miriam Jacob, Gary W Procop, Mina K Chung, JAMA Cardiology
Authored Content
- Association of Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers with Testing Positive for Coronavirus Disease 2019 (COVID-19)May 2020
- Association of Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers with Testing Positive for Coronavirus Disease 2019 (COVID-19)May 2020
Press Mentions
Lab Test Use: What 1 Billion Claims Tell UsAugust 3rd, 2024- Pathology Power List 2021: 75 HonoredAugust 18th, 2021
- People Don’t Seem to Be as Interested in Testing for COVID Anymore — Why?April 21st, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
